Aoxing Pharmaceutical
Foster City
About Aoxing Pharmaceutical
Aoxing Pharmaceutical Company, Inc (NYSE AMEX: AXN) is registered in Florida in US and it is a specialty pharmaceutical company which specializes in research, development, manufacturing and distribution of a variety of narcotics and pain-management products and drug-relief medicine. Aoxing has its office in Jersey city and headquartered in Shijiazhuang City, outside Beijing, Aoxing has the largest and most advanced manufacturing facility for highly regulated narcotic medicines. Its facility is one of the few GMP facilities licensed for the manufacture of narcotic medicines by the China State Food and Drug Administration (SFDA). It has strategic alliance partnerships with Johnson Matthey Plc (LSE: JMAT), QRx Pharma (ASX: QRX) and American Oriental Bioengineering, Inc (NYSE: AOB).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Total funding: $5.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2010)
- Ticker: nyse:AXN
- Website: aoxingpharma.com
- Phone: 86 311 8519 6969
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/aoxing-pharmaceutical-1912732 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.